Schedule 13D ownership disclosure

INDIVIOR PLC

Ordinary Shares, $0.50 nominal value per share · CUSIP: G4766E116

Event date: 2025-02-28

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Oaktree Value Opportunities Fund, L.P.

    Shares: 6,237,438 · Class: 5%

  • Oaktree London Liquid Value Opportunities Fund (VOF), L.P.

    Shares: 2,594,929 · Class: 2.1%

  • Oaktree Phoenix Investment Fund, L.P.

    Shares: 367,390 · Class: 0.3%

  • Oaktree Capital Management, L.P.

    Shares: 1,516,134 · Class: 1.2%

  • Oaktree Fund GP I, L.P.

    Shares: 9,199,757 · Class: 7.4%

  • Oaktree Capital Holdings, LLCReported CIK 0001790787

    Shares: 10,715,891 · Class: 8.6%

  • Oaktree Capital Group Holdings GP, LLC

    Shares: 10,715,891 · Class: 8.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-25-007015
Form type
SCHEDULE 13D/A
Filer
Indivior Pharmaceuticals, Inc.
CIK
CIK 1625297
Filed
Mar 04, 2025
Reporting period
Feb 28, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub